예측 기간
시장 규모(기준 연도)
시장 규모(예측 연도)
연평균 성장률북미 지방 감량 시장, 유형별(외과적 지방 감량, 비침습적 지방 감량, 최소 침습적), 응용 분야별(복부 지방, 허벅지 지방, 엉덩이 지방, 상완 지방, 얼굴 지방 축적, 무릎 지방), 성별(여성 및 남성), 연령대별(성인, 노인, 어린이), 최종 사용자(병원, 종합 병원, 피부과 센터, 메디컬 스파 및 뷰티 센터, 기타), 유통 채널(직접 입찰, 소매 판매, 제3자 유통업체, 기타), 업계 동향 및 2033년까지의 예측.
북미 지방 감소 시장 분석 및 통찰력
북미 지방 감소 시장은 최소 침습적 및 비침습적 시술에 대한 수요 증가와 미적 기능에 대한 남녀 간 격차 감소로 인해 예측 기간 동안 성장할 것으로 예상됩니다. 이 시장은 또한 증가하는 미적 의식과 아름다움 기준, 증가하는 기술 발전의 영향을 받습니다. 그러나 북미 지방 감소 시장은 시술 비용이 높고, 시술과 관련된 위험이 증가하고, 제품 리콜이 발생하여 방해를 받을 것으로 예상됩니다.
맞춤형 치료 계획과 다른 미용 시술, 신념, 젊은 성인의 지방 감소 추세와의 통합, 포용성과 다양성에 대한 집중, 제품 라인의 확장은 시장 성장의 기회로 작용할 것으로 예상됩니다. 그러나 시술의 낮은 장기 효능과 지속 가능성, 긴 회복 시간은 시장 성장에 도전할 것으로 예상됩니다.
지방 감소 시장에 대한 수요는 선진국과 개발도상국 모두에서 증가했으며, 그 이유는 효과와 가용성 때문입니다. 따라서 많은 시장 참여자들이 북미 지방 감소 시장의 성장을 위한 길을 여는 혁신을 통해 지방 감소 제품을 제공합니다.
Data Bridge Market Research에 따르면, 북미 지방 감량 시장은 2033년까지 11,773.56백만 달러 규모에 도달할 것으로 예상되며, 이는 예측 기간 동안 연평균 성장률 9.9%를 기록할 것으로 예측됩니다.
|
보고서 메트릭 |
세부 |
|
예측 기간 |
2023년부터 2033년까지 |
|
기준 연도 |
2022 |
|
역사적 연도 |
2021 (2015-2020까지 사용자 정의 가능) |
|
양적 단위 |
수익 (단위: USD 백만) |
|
다루는 세그먼트 |
유형(외과적 지방 감소, 비침습적 지방 감소 및 최소 침습적), 적용(복부 지방, 허벅지 지방, 엉덩이 지방, 상완 지방, 얼굴 지방 축적 및 무릎 지방), 성별(여성 및 남성), 연령대(성인, 노인 및 어린이), 최종 사용자(병원, 다분야 클리닉, 피부과 센터, 의료 스파 및 뷰티 센터 및 기타), 유통 채널(직접 입찰, 소매 판매, 제3자 유통업체 및 기타) |
|
적용 국가 |
미국, 캐나다, 멕시코, 코스타리카, 도미니카 공화국, 파나마, 엘살바도르, 과테말라, 온두라스, 니카라과 |
|
시장 참여자 포함 |
Hironic Co Ltd, AbbVie Inc., Cynosure, Alma Lasers, Candela Corporation, Merz Pharma, Solta Medical(Bausch & Lomb Incorporated의 자회사), Cutera, MicroAire Surgical Instruments, LLC., Mentor Worldwide LLC, Venus Concept, Erchonia Corporation, BTL Group of Companies, Leaderma Inc., MÖLLER Medical, Fotona, Implantech 등이 있습니다. |
북미 지방 감소 시장 정의
지방 감소는 개인의 신체에서 체지방이나 지방 조직의 양을 줄이는 것을 말합니다. 여기에는 체중 감량을 촉진하고 체지방의 전체 비율을 줄이는 것을 목표로 하는 전략과 기술이 포함됩니다. 체지방 감소는 수술 및 비수술적 시술을 통해 수행할 수 있습니다. 레이저 지방 분해술, 크라이 지방 분해술, 지방 흡입술, 주사 치료 등 다양한 치료법이 있습니다.
북미 지방 감소 시장 역학
이 섹션에서는 시장 동인, 이점, 기회, 제약 및 과제를 이해하는 것을 다룹니다. 이 모든 내용은 아래에서 자세히 설명합니다.
운전자
- 최소 침습 및 비침습 시술에 대한 수요 증가
최소 침습적 및 비침습적 시술의 사용은 레이저 및 기타 에너지 기반 장치를 포함한 지방 감소 기술의 기존 방법과 비교했을 때 변화했습니다. 수술 또는 비수술적 시술을 사용하기 위해 최소한으로 사용되는 시술을 위해 특별히 설계된 기구가 개발되었습니다.
최소 침습 수술은 시야 범위와 특수 장비 수술 도구의 도움을 받아 수행하는 시술입니다. 최소 침습 시술을 사용하면 절개 없이 또는 최소한의 절개로 회복 시간이 단축되어 최소 침습 시술에 대한 수요와 사용이 증가합니다. 시술이 증가하는 다른 이유는 고령 인구의 증가와 의료 적 요구 사항이 최대인 환자 친화적 기술을 포함한 의료 시설에 대한 요구로 정의할 수 있으며, 이는 의료 시설의 부담을 더욱 줄일 수 있습니다.
최소 침습/비침습 시술은 환자의 편안함과 일치합니다. 부작용이 거의 없고 회복 시간도 너무 짧습니다. 따라서 사람들은 심미적 향상을 위해 시술을 받는 것을 더 편안하게 느낍니다. 따라서 최소 침습 및 비침습 시술에 대한 수요 증가가 시장을 주도할 것으로 예상됩니다.
제지
- 높은 시술 비용
최신 기술 기반 지방 감소 장치는 초음파 기반, 레이저 지원 또는 고주파 지원 지방 감소 장치와 같은 기술적으로 진보된 방식을 사용하여 지방을 감소시켜 다양한 신체 부위를 탄력 있게 만들고 조여줍니다. 지방 감소 비용은 장소 또는 지역마다 상당히 다릅니다. 지방 감소 비용을 결정하는 주요 요인에는 시술을 위해 확정된 의료 기관 또는 클리닉, 치료 영역, 영향을 받는 부위, 환자의 체류 기간 및 수술의 복잡성과 같은 요인이 포함됩니다. 시술 비용이 높은 이유는 이러한 시술을 수행하기 위한 첨단 방식을 사용하는 것과 함께 수술의 다양한 체크포인트 때문입니다. 기술적으로 진보된 지방 감소 장치의 비용이 높기 때문에 시술 비용도 비례적으로 상승하여 시술 비용이 높아 시장 수요를 저해할 것으로 예상됩니다.
기회
- 맞춤형 치료 계획 및 기타 미용 시술과의 통합
맞춤형 치료 계획과 지방 감소 시술을 다른 미용 시술과 통합함으로써 북미 지방 감소 시장의 회사들은 맞춤형 솔루션을 제공하고 고객에게 전반적인 치료 경험을 향상시킬 수 있습니다. 이러한 전략은 결과를 최적화할 뿐만 아니라 개별적인 요구와 선호도를 충족하고 고객 만족과 충성도를 높이는 데 전념하는 것을 보여줍니다. 따라서 맞춤형 치료 계획과 다른 미용 시술과의 통합은 시장 성장의 기회를 창출할 것으로 기대됩니다.
도전
- 장기 효능 및 지속 가능성
치료 결과는 신진대사, 유전학, 라이프스타일 요인과 같은 요소에 의해 영향을 받을 수 있습니다. 어떤 사람들은 더 극적이고 오래 지속되는 이점을 얻을 수 있지만, 다른 사람들은 원하는 결과를 얻기 위해 더 많은 세션이나 추가 치료가 필요할 수 있습니다. 지속적인 지방 축적을 다룰 때 장기적인 효과를 유지하는 것도 문제가 됩니다. 체지방을 줄이는 치료는 하복부나 러브 핸들과 같은 특정 신체 부위에는 덜 효과적일 수 있습니다.
장기적인 효능과 지속 가능성은 북미 지방 감량 시장의 중요한 과제이며, 시장 성장에 어려움을 겪을 것으로 예상됩니다.
최근 개발 사항
- 2023년 10월, MOLLER Medical은 2023년 6월 1일부터 6월 3일까지 SOFCEP Congress 2023이라는 이벤트를 개최할 예정입니다. 이 이벤트는 미용 의학과 미용 의학 제스처와 개입 간의 상호 보완성을 주제로 합니다. 이를 통해 회사는 더 많은 고객 기반에 도달할 수 있습니다.
- Implantech는 2023년 8월 미국 샌디에이고의 Marriot Marquis Hotel에서 열리는 제2회 Multispecialty Aesthetics Conference에서 해당 행사를 개최할 예정입니다. 이 컨퍼런스는 회사가 임플란트 분야에서 혁신을 선보이는 데 도움이 될 것입니다.
- 2023년 5월, 하이로닉(주)은 27일 서울 중구 한국프레스센터에서 열린 머니투데이 '2023 소비자만족대상'에서 뷰티·의료기기 부문 대상을 수상했다고 밝혔습니다. 이를 통해 기업의 브랜드 이미지 제고에 기여할 것으로 기대됩니다.
- 2023년 1월 Fotona는 IMCAS 의회에서 미용 제품 포트폴리오를 선보였다고 발표했습니다. 내장형 CoolMist 피부 냉각 및 옵션 Dynamic Vacuum Technology가 포함된 미용 포트폴리오인 SP Dynamis Nx Line 레이저 시스템과 AvalancheLase, TimeWalker Fotona4D와 같은 다른 Fotona 제품 및 애플리케이션을 선보였으며, 이를 통해 회사가 더 높은 고객 기반에 도달하는 데 도움이 될 것이라고 밝혔습니다.
- Cutera는 2019년 6월에 근육 조형 시장을 위한 truSculpt Flex라는 신제품을 출시했습니다. 이 회사가 출시한 이 신제품은 의료 미용 부문에서 제품 포트폴리오를 늘려 시장에서 제품에 대한 수요가 증가했습니다.
북미 지방 감소 시장 범위
북미 지방 감소 시장은 유형, 응용 프로그램, 성별, 연령대, 최종 사용자 및 유통 채널과 같은 6가지 주요 세그먼트로 세분화됩니다. 세그먼트 간의 성장은 틈새 성장 포켓과 시장에 접근하고 핵심 응용 분야와 타겟 시장의 차이점을 파악하기 위한 전략을 분석하는 데 도움이 됩니다.
유형
- 수술적 지방 감소
- 비침습적 지방 감소
- 최소 침습적
북미 지방 감량 시장은 유형에 따라 수술적 지방 감량, 비침습적 지방 감량, 최소 침습적 지방 감량으로 구분됩니다.
애플리케이션
- 복부 지방
- 허벅지 지방
- 엉덩이 지방
- 상완부 지방
- 얼굴 지방 축적
- 무릎 지방
북미 지방 감량 시장은 응용 분야별로 복부 지방, 허벅지 지방, 엉덩이 지방, 상완 지방, 얼굴 지방 축적, 무릎 지방으로 구분됩니다.
성별
- 여성
- 남성
성별을 기준으로 북미 지방 감량 시장은 남성과 여성으로 구분됩니다.
연령대
- 성인
- 노인
- 어린이
북미 지방 감량 시장은 연령대를 기준으로 성인, 노인, 어린이로 구분됩니다.
최종 사용자
- 병원
- 다분야 진료소
- 피부과 센터
- 의료 스파 및 뷰티 센터
- 기타
북미 지방 감량 시장은 최종 사용자를 기준으로 병원, 종합병원, 피부과 센터, 메디컬 스파 , 뷰티 센터로 구분됩니다.
유통 채널
- 직접 입찰
- 소매 판매
- 제3자 유통업체
- 기타
북미 지방 감량 시장은 유통 채널을 기준으로 직접 입찰 및 소매 판매, 제3자 유통업체 및 기타로 구분됩니다.
북미 지방 감소 시장 지역 분석/통찰력
북미 지방 감량 시장은 유형, 응용 분야, 성별, 연령대, 최종 사용자, 유통 채널 등 6가지 주요 부문으로 분류됩니다.
이 시장 보고서에 포함된 국가로는 미국, 캐나다, 멕시코, 코스타리카, 도미니카 공화국, 파나마, 엘살바도르, 과테말라, 온두라스, 니카라과가 있습니다.
미국은 GDP가 높은 최대 소비자 시장에 주요 시장 참여자들이 존재하기 때문에 북미 지방 감량 시장을 지배할 것으로 예상됩니다.
보고서의 국가 섹션은 또한 개별 시장 영향 요인과 국내 시장의 현재 및 미래 트렌드에 영향을 미치는 규제 변화를 제공합니다. 신규 판매, 교체 판매, 국가 인구 통계, 규제 조치 및 수출입 관세와 같은 데이터 포인트는 개별 국가의 시장 시나리오를 예측하는 데 사용되는 주요 포인터 중 일부입니다. 또한 북미 브랜드의 존재 및 가용성과 지역 및 국내 브랜드와의 대규모 또는 희소한 경쟁으로 인해 직면한 과제, 판매 채널의 영향이 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다.
경쟁 환경 및 북미 지방 감소 시장 점유율 분석
북미 지방 감소 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, R&D 투자, 새로운 시장 이니셔티브, 생산 현장 및 시설, 회사의 강점과 약점, 제품 출시, 제품 승인, 제품 폭과 호흡, 응용 프로그램 우세 및 제품 유형 수명선 곡선입니다. 위에 제공된 데이터 포인트는 회사가 북미 지방 감소 시장에 집중하는 것과만 관련이 있습니다.
북미 지방 감량 시장의 주요 기업으로는 Hironic Co Ltd, AbbVie Inc., Cynosure, Alma Lasers, Candela Corporation, Merz Pharma, Solta Medical(Bausch & Lomb Incorporated의 자회사), Cutera, MicroAire Surgical Instruments, LLC., Mentor Worldwide LLC, Venus Concept, Erchonia Corporation, BTL Group of Companies, Leaderma Inc., MÖLLER Medical, Fotona, Implantech 등이 있습니다.
SKU-
세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요
- 대화형 데이터 분석 대시보드
- 높은 성장 잠재력 기회를 위한 회사 분석 대시보드
- 사용자 정의 및 질의를 위한 리서치 분석가 액세스
- 대화형 대시보드를 통한 경쟁자 분석
- 최신 뉴스, 업데이트 및 추세 분석
- 포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용
목차
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE NORTH AMERICA FAT REDUCTION MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 TYPE LIFELINE CURVE
2.8 DBMR MARKET POSITION GRID
2.9 VENDOR SHARE ANALYSIS
2.1 MARKET APPLICATION COVERAGE GRID
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHT
4.1 PESTEL ANALYSIS
4.2 PORTER’S FIVE FORCES
4.3 BRAND ANALYSIS
4.3.1 KYBELLA
5 INDUSTRY INSIGHTS:
6 NORTH AMERICA FAT REDUCTION MARKET, REGULATIONS
6.1 U.S.
6.1.1 REGULATORY APPROVAL PROCESS, PATHWAYS, AND TIMELINE:
6.1.2 POST-MARKETING SURVEILLANCE:
6.1.3 GOOD MANUFACTURING PRACTICES (GMPS) GUIDELINES:
6.2 CANADA
6.2.1 REGULATORY APPROVAL PROCESS, PATHWAYS, AND TIMELINE
6.2.2 LICENSING AND REGISTRATION
6.2.3 POST EXPIRY OF PATENT REGIME
6.2.4 POST-MARKETING SURVEILLANCE
6.3 MEXICO
6.3.1 REGULATORY APPROVAL PROCESS, PATHWAYS, AND TIMELINE
6.3.2 REGULATORY APPROVAL AGENCIES
6.3.3 LICENSING AND REGISTRATION
6.3.4 POST-MARKETING SURVEILLANCE
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 INCREASING DEMAND FOR MINIMALLY INVASIVE AND NON-INVASIVE PROCEDURES
7.1.2 GROWING AESTHETIC CONSCIOUSNESS AND BEAUTY STANDARDS
7.1.3 GROWING TECHNOLOGICAL ADVANCEMENTS
7.1.4 DECREASED DISPARITY BETWEEN MEN AND WOMEN FOR AESTHETIC PROCEDURES
7.2 RESTRAINTS
7.2.1 HIGH COST OF PROCEDURES
7.2.2 INCREASED RISKS ASSOCIATED WITH THE PROCEDURES
7.2.3 PRODUCT RECALL
7.3 OPPORTUNITIES
7.3.1 CUSTOMIZED TREATMENT PLANS AND INTEGRATION WITH OTHER AESTHETIC PROCEDURES
7.3.2 BELIEF AND TREND OF FAT REDUCTION IN YOUNG ADULTS
7.3.3 FOCUS ON INCLUSIVITY AND DIVERSITY AND EXPANSION OF PRODUCT LINES
7.4 CHALLENGES
7.4.1 LONG-TERM EFFICACY AND SUSTAINABILITY
7.4.2 LONGER RECOVERY TIME OF THE PROCEDURE
8 NORTH AMERICA FAT REDUCTION MARKET, BY TYPE
8.1 OVERVIEW
8.2 SURGICAL FAT REDUCTION
8.2.1 LIPOSUCTION
8.2.1.1 BY TYPE
8.2.1.1.1 ULTRASOUND-ASSISTED LIPOSUCTION
8.2.1.1.2 LASER-ASSISTED LIPOSUCTION
8.2.1.1.3 TUMESCENT LIPOSUCTION
8.2.1.1.4 SUPER-WET TECHNIQUE
8.2.1.2 BY APPLICATION
8.2.1.2.1 ABDOMINAL FAT
8.2.1.2.2 THIGHS FAT
8.2.1.2.3 BUTTOCK FAT
8.2.1.2.4 UPPER-ARM FAT
8.2.1.2.5 FACIAL FAT-DEPOSITS
8.2.1.2.5.1 SUBMENTAL AREAS
8.2.1.2.5.2 MALAR
8.2.1.2.5.3 MANDIBULAR
8.2.1.2.6 KNEE FAT
8.2.2 SURGICAL REJUVENATION
8.2.2.1 FACE LIFT
8.2.2.2 NECK LIFT
8.2.3 CHIN IMPLANT
8.2.3.1 SILICONE CHIN IMPLANTS
8.2.3.2 OTHERS
8.2.4 PORUS IMPLANTS
8.2.4.1 TEFLON
8.2.4.2 GORE-TEX
8.2.4.3 MEDPORE IMPLANTS
8.3 NON-INVASIVE FAT REDUCTION
8.3.1 CRYOLIPOLYSIS
8.3.1.1 COOL SCULPTING
8.3.1.2 COOL SCULPTING ELITE
8.3.1.3 COOL TONE
8.3.1.4 OTHERS
8.3.1.4.1 ABDOMINAL FAT
8.3.1.4.2 THIGHS FAT
8.3.1.4.3 BUTTOCK FAT
8.3.1.4.4 UPPER-ARM FAT
8.3.1.4.5 FACIAL FAT-DEPOSITS
8.3.1.4.6 KNEE FAT
8.3.2 ULTRASOUND
8.3.2.1 INTERNAL ULTRASONIC LIPOSUCTION
8.3.2.2 EXTERNAL ULTRASONIC LIPOSUCTION
8.3.2.2.1 ABDOMINAL FAT
8.3.2.2.2 THIGHS FAT
8.3.2.2.3 BUTTOCK FAT
8.3.2.2.4 UPPER-ARM FAT
8.3.2.2.5 FACIAL FAT-DEPOSITS
8.3.2.2.6 KNEE FAT
8.3.3 RADIOFREQUENCY
8.3.3.1 ABDOMINAL FAT
8.3.3.2 THIGHS FAT
8.3.3.3 BUTTOCK FAT
8.3.3.4 UPPER-ARM FAT
8.3.3.5 FACIAL FAT-DEPOSITS
8.3.3.6 KNEE FAT
8.3.4 LOW LEVEL LASER THERAPY
8.3.4.1 ABDOMINAL FAT
8.3.4.2 THIGHS FAT
8.3.4.3 BUTTOCK FAT
8.3.4.4 UPPER-ARM FAT
8.3.4.5 FACIAL FAT-DEPOSITS
8.3.4.6 KNEE FAT
8.3.5 OTHERS
8.4 MINIMALLY INVASIVE
8.4.1 INJECTION LIPOLYSIS
8.4.1.1 DEOXYCHOLIC ACID INJECTIONS
8.4.1.1.1 KYBELLA/BELKYRA
8.4.1.1.1.1 FACIAL FAT-DEPOSITS
8.4.1.1.1.2 UPPER-ARM FAT
8.4.1.1.1.3 ABDOMINAL FAT
8.4.1.1.1.4 THIGHS FAT
8.4.1.1.1.5 KNEE FAT
8.4.1.1.1.6 BUTTOCK FAT
8.4.1.2 PHOSPHATIDYLCHOLINE
8.4.1.2.1 FACIAL FAT-DEPOSITS
8.4.1.2.2 UPPER-ARM FAT
8.4.1.2.3 ABDOMINAL FAT
8.4.1.2.4 THIGHS FAT
8.4.1.2.5 KNEE FAT
8.4.1.2.6 BUTTOCK FAT
8.4.2 OTHERS
9 NORTH AMERICA FAT REDUCTION MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 ABDOMINAL FAT
9.3 THIGHS FAT
9.4 BUTTOCK FAT
9.5 UPPER-ARM FAT
9.6 FACIAL FAT-DEPOSITS
9.6.1 SUBMENTAL AREAS
9.6.2 MANDIBULAR
9.6.3 MALAR
9.7 KNEE FAT
10 NORTH AMERICA FAT REDUCTION MARKET, BY GENDER
10.1 OVERVIEW
10.2 FEMALE
10.3 MALE
11 NORTH AMERICA FAT REDUCTION MARKET, BY AGE GROUP
11.1 OVERVIEW
11.2 ADULT
11.3 GERIATRIC
11.4 CHILD
12 NORTH AMERICA FAT REDUCTION MARKET, BY END USER
12.1 OVERVIEW
12.2 HOSPITALS
12.2.1 BY TYPE
12.2.1.1 PRIVATE
12.2.1.2 PUBLIC
12.2.2 BY CATEGORY
12.2.2.1 TIER 1
12.2.2.2 TIER 2
12.2.2.3 TIER 3
12.3 MULTISPECIALTY CLINICS
12.4 DERMATOLOGY CENTERS
12.5 MEDICAL SPAS AND BEAUTY CENTERS
12.6 OTHERS
13 NORTH AMERICA FAT REDUCTION MARKET, BY DISTRIBUTION CHANNEL
13.1 OVERVIEW
13.2 DIRECT TENDERS
13.3 RETAIL SALES
13.4 THIRD PARTY DISTRIBUTORS
13.5 OTHERS
14 NORTH AMERICA FAT REDUCTION MARKET, BY COUNTRY
14.1 NORTH AMERICA
14.1.1 U.S.
14.1.2 CANADA
14.1.3 MEXICO
14.1.4 COSTA RICA
14.1.5 DOMINICAN REPUBLIC
14.1.6 PANAMA
14.1.7 EL SALVADOR
14.1.8 GUATEMALA
14.1.9 HONDURAS
14.1.10 NICARAGUA
15 COMPANY SHARE ANALYSIS: NORTH AMERICA
16 SWOT ANALYSIS
17 NORTH AMERICA FAT REDUCTION MARKET, COMPANY PROFILINGS
17.1 ABBVIE INC.
17.1.1 COMPANY SNAPSHOT
17.1.2 REVENUE ANALYSIS
17.1.3 PRODUCT PORTFOLIO
17.1.4 RECENT DEVELOPMENTS
17.2 CYNOSURE
17.2.1 COMPANY SNAPSHOT
17.2.2 PRODUCT PORTFOLIO
17.2.3 RECENT DEVELOPMENTS
17.3 ALMA LASERS
17.3.1 COMPANY SNAPSHOT
17.3.2 PRODUCT PORTFOLIO
17.3.3 RECENT DEVELOPMENT
17.4 CANDELA CORPORATION
17.4.1 COMPANY SNAPSHOT
17.4.2 PRODUCT PORTFOLIO
17.4.3 RECENT DEVELOPMENT
17.5 MERZ NORTH AMERICA, INC.
17.5.1 COMPANY SNAPSHOT
17.5.2 PRODUCT PORTFOLIO
17.5.3 RECENT DEVELOPMENTS
17.6 BLACK & BLACK SURGICAL
17.6.1 COMPANY SNAPSHOT
17.6.2 PRODUCT PORTFOLIO
17.6.3 RECENT DEVELOPMENT
17.7 BTL GROUP OF COMPANIES
17.7.1 COMPANY SNAPSHOT
17.7.2 PRODUCT PORTFOLIO
17.7.3 RECENT DEVELOPMENTS
17.8 BAUSCH HEALTH COMPANIES INC.
17.8.1 COMPANY SNAPSHOT
17.8.2 REVENUE ANALYSIS
17.8.3 PRODUCT PORTFOLIO
17.8.4 RECENT DEVELOPMENT
17.9 CUTERA
17.9.1 COMPANY SNAPSHOT
17.9.2 REVENUE ANALYSIS
17.9.3 PRODUCT PORTFOLIO
17.9.4 RECENT DEVELOPMENT
17.1 ERCHONIA CORPORATION
17.10.1 COMPANY SNAPSHOT
17.10.2 PRODUCT PORTFOLIO
17.10.3 RECENT DEVELOPMENT
17.11 FOTONA
17.11.1 COMPANY SNAPSHOT
17.11.2 PRODUCT PORTFOLIO
17.11.3 RECENT DEVELOPMENT
17.12 GENESIS BIOSYSTEMS, INC.
17.12.1 COMPANY SNAPSHOT
17.12.2 PRODUCT PORTFOLIO
17.12.3 RECENT DEVELOPMENT
17.13 HIRONIC CO., LTD.
17.13.1 COMPANY SNAPSHOT
17.13.2 REVENUE ANALYSIS
17.13.3 PRODUCT PORTFOLIO
17.13.4 RECENT DEVELOPMENT
17.14 IMPLANTECH
17.14.1 COMPANY SNAPSHOT
17.14.2 PRODUCT PORTFOLIO
17.14.3 RECENT DEVELOPMENTS
17.15 LEADERMA INC.
17.15.1 COMPANY SNAPSHOT
17.15.2 PRODUCT PORTFOLIO
17.15.3 RECENT DEVELOPMENT
17.16 LYNTON LASERS LTD
17.16.1 COMPANY SNAPSHOT
17.16.2 PRODUCT PORTFOLIO
17.16.3 RECENT DEVELOPMENT
17.17 MENTOR WORLDWIDE LLC (A PART OF JOHNSON & JOHNSON SERVICES, INC.)
17.17.1 COMPANY SNAPSHOT
17.17.2 REVENUE ANALYSIS
17.17.3 PRODUCT PORTFOLIO
17.17.4 RECENT DEVELOPMENT
17.18 MICROAIRE SURGICAL INSTRUMENTS, LLC.
17.18.1 COMPANY SNAPSHOT
17.18.2 PRODUCT PORTFOLIO
17.18.3 RECENT DEVELOPMENT
17.19 MOLLER MEDICAL
17.19.1 COMPANY SNAPSHOT
17.19.2 PRODUCT PORTFOLIO
17.19.3 RECENT DEVELOPMENT
17.2 POLLOGEN (A SUBSIDIARY OF LUMENIS BE LTD.)
17.20.1 COMPANY SNAPSHOT
17.20.2 PRODUCT PORTFOLIO
17.20.3 RECENT DEVELOPMENT
17.21 SILIMED
17.21.1 COMPANY SNAPSHOT
17.21.2 PRODUCT PORTFOLIO
17.21.3 RECENT DEVELOPMENTS
17.22 SURGIFORM INNOVATIVE SURGICAL PRODUCTS
17.22.1 COMPANY SNAPSHOT
17.22.2 PRODUCT PORTFOLIO
17.22.3 RECENT DEVELOPMENT
17.23 VENUS CONCEPT
17.23.1 COMPANY SNAPSHOT
17.23.2 REVENUE ANALYSIS
17.23.3 PRODUCT PORTFOLIO
17.23.4 RECENT DEVELOPMENT
18 QUESTIONNAIRE
19 RELATED REPORTS
표 목록
TABLE 1 AVERAGE COST OF LIPOSUCTION ACROSS THE U.S.
TABLE 2 AVERAGE COSTS OF CHIN AUGMENTATION ACROSS THE U.S.
TABLE 3 NORTH AMERICA FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 4 NORTH AMERICA SURGICAL FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 5 NORTH AMERICA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 6 NORTH AMERICA LIPOSUCTION IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 7 NORTH AMERICA FACIAL FAT-DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 8 NORTH AMERICA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 9 NORTH AMERICA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (USD MILLION)
TABLE 10 NORTH AMERICA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 11 NORTH AMERICA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 12 NORTH AMERICA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 13 NORTH AMERICA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 14 NORTH AMERICA ULTRASOUND IN FAT REDUCTION MARKET, BY REGION, 2019-2033 (USD MILLION)
TABLE 15 NORTH AMERICA ULTRASOUND IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 16 NORTH AMERICA RADIOFREQUENCY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 17 NORTH AMERICA LOW-LEVEL LASER THERAPY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 18 NORTH AMERICA MINIMALLY INVASIVE IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 19 NORTH AMERICA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 20 NORTH AMERICA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (USD MILLION)
TABLE 21 NORTH AMERICA KYBELLA/BELKYRA IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 22 NORTH AMERICA PHOSPHATIDYLCHOLINE IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 23 NORTH AMERICA FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 24 NORTH AMERICA FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 25 NORTH AMERICA FAT REDUCTION MARKET, BY GENDER, 2019-2033 (USD MILLION)
TABLE 26 NORTH AMERICA FAT REDUCTION MARKET, BY AGE GROUP, 2019-2033 (USD MILLION)
TABLE 27 NORTH AMERICA FAT REDUCTION MARKET, BY END USER, 2019-2033 (USD MILLION)
TABLE 28 NORTH AMERICA HOSPITALS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 29 NORTH AMERICA HOSPITALS IN FAT REDUCTION MARKET, BY CATEGORY, 2019-2033 (USD MILLION)
TABLE 30 NORTH AMERICA FAT REDUCTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2033 (USD MILLION)
TABLE 31 U.S. FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 32 U.S. SURGICAL FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 33 U.S. LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 34 U.S. LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 35 U.S. LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 36 U.S. LIPOSUCTION IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 37 U.S. FACIAL FAT-DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 38 U.S. SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 39 U.S. SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 40 U.S. SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 41 U.S. CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (USD MILLION)
TABLE 42 U.S. CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 43 U.S. CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 ASP
TABLE 44 U.S. PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 45 U.S. PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 46 U.S. PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 47 U.S. NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 48 U.S. NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 49 U.S. NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 50 U.S. CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 51 U.S. CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 52 U.S. CRYOLYPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 53 U.S. CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 54 U.S.ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 55 U.S. ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 56 U.S. ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 57 U.S. ULTRASOUND IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 58 U.S. RADIOFREQUENCY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 59 U.S. LOW-LEVEL LASER THERAPY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 60 U.S. MINIMALLY INVASIVE IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 61 U.S. INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 62 U.S. INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 63 U.S. INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 64 U.S. DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (USD MILLION)
TABLE 65 U.S. DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 66 U.S. DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 ASP
TABLE 67 U.S. KYBELLA/BELKYRA IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 68 U.S. PHOSPHATIDYLCHOLINE IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 69 U.S. FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 70 U.S. FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 71 U.S. FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP
TABLE 72 U.S. FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 73 U.S. FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 74 U.S. FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP
TABLE 75 U.S. FAT REDUCTION MARKET, BY GENDER, 2019-2033 (USD MILLION)
TABLE 76 U.S. FAT REDUCTION MARKET, BY AGE GROUP, 2019-2033 (USD MILLION)
TABLE 77 U.S. FAT REDUCTION MARKET, BY END USER, 2019-2033 (USD MILLION)
TABLE 78 U.S. HOSPITALS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 79 U.S. HOSPITALS IN FAT REDUCTION MARKET, BY CATEGORY, 2019-2033 (USD MILLION)
TABLE 80 U.S. FAT REDUCTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2033 (USD MILLION)
TABLE 81 CANADA FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 82 CANADA SURGICAL FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 83 CANADA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 84 CANADA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 85 CANADA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 86 CANADA LIPOSUCTION IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 87 CANADA FACIAL FAT-DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 88 CANADA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 89 CANADA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 90 CANADA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 91 CANADA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (USD MILLION)
TABLE 92 CANADA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 93 CANADA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 ASP
TABLE 94 CANADA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 95 CANADA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 96 CANADA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 97 CANADA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 98 CANADA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 99 CANADA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 100 CANADA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 101 CANADA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 102 CANADA CRYOLYPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 103 CANADA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 104 CANADAULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 105 CANADA ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 106 CANADA ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 107 CANADA ULTRASOUND IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 108 CANADA RADIOFREQUENCY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 109 CANADA LOW-LEVEL LASER THERAPY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 110 CANADA MINIMALLY INVASIVE IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 111 CANADA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 112 CANADA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 113 CANADA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 114 CANADA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (USD MILLION)
TABLE 115 CANADA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 116 CANADA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 ASP
TABLE 117 CANADA KYBELLA/BELKYRA IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 118 CANADA PHOSPHATIDYLCHOLINE IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 119 CANADA FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 120 CANADA FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 121 CANADA FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP
TABLE 122 CANADA FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 123 CANADA FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 124 CANADA FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP
TABLE 125 CANADA FAT REDUCTION MARKET, BY GENDER, 2019-2033 (USD MILLION)
TABLE 126 CANADA FAT REDUCTION MARKET, BY AGE GROUP, 2019-2033 (USD MILLION)
TABLE 127 CANADA FAT REDUCTION MARKET, BY END USER, 2019-2033 (USD MILLION)
TABLE 128 CANADA HOSPITALS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 129 CANADA HOSPITALS IN FAT REDUCTION MARKET, BY CATEGORY, 2019-2033 (USD MILLION)
TABLE 130 CANADA FAT REDUCTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2033 (USD MILLION)
TABLE 131 MEXICO FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 132 MEXICO SURGICAL FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 133 MEXICO LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 134 MEXICO LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 135 MEXICO LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 136 MEXICO LIPOSUCTION IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 137 MEXICO FACIAL FAT-DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 138 MEXICO SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 139 MEXICO SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 140 MEXICO SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 141 MEXICO CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (USD MILLION)
TABLE 142 MEXICO CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 143 MEXICO CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 ASP
TABLE 144 MEXICO PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 145 MEXICO PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 146 MEXICO PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 147 MEXICO NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 148 MEXICO NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 149 MEXICO NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 150 MEXICO CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 151 MEXICO CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 152 MEXICO CRYOLYPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 153 MEXICO CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 154 MEXICOULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 155 MEXICO ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 156 MEXICO ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 157 MEXICO ULTRASOUND IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 158 MEXICO RADIOFREQUENCY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 159 MEXICO LOW-LEVEL LASER THERAPY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 160 MEXICO MINIMALLY INVASIVE IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 161 MEXICO INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 162 MEXICO INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 163 MEXICO INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 164 MEXICO DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (USD MILLION)
TABLE 165 MEXICO DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 166 MEXICO DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 ASP
TABLE 167 MEXICO KYBELLA/BELKYRA IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 168 MEXICO PHOSPHATIDYLCHOLINE IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 169 MEXICO FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 170 MEXICO FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 171 MEXICO FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP
TABLE 172 MEXICO FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 173 MEXICO FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 174 MEXICO FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP
TABLE 175 MEXICO FAT REDUCTION MARKET, BY GENDER, 2019-2033 (USD MILLION)
TABLE 176 MEXICO FAT REDUCTION MARKET, BY AGE GROUP, 2019-2033 (USD MILLION)
TABLE 177 MEXICO FAT REDUCTION MARKET, BY END USER, 2019-2033 (USD MILLION)
TABLE 178 MEXICO HOSPITALS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 179 MEXICO HOSPITALS IN FAT REDUCTION MARKET, BY CATEGORY, 2019-2033 (USD MILLION)
TABLE 180 MEXICO FAT REDUCTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2033 (USD MILLION)
TABLE 181 COSTA RICA FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 182 COSTA RICA SURGICAL FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 183 COSTA RICA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 184 COSTA RICA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 185 COSTA RICA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 186 COSTA RICA LIPOSUCTION IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 187 COSTA RICA FACIAL FAT-DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 188 COSTA RICA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 189 COSTA RICA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 190 COSTA RICA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 191 COSTA RICA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (USD MILLION)
TABLE 192 COSTA RICA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 193 COSTA RICA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 ASP
TABLE 194 COSTA RICA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 195 COSTA RICA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 196 COSTA RICA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 197 COSTA RICA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 198 COSTA RICA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 199 COSTA RICA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 200 COSTA RICA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 201 COSTA RICA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 202 COSTA RICA CRYOLYPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 203 COSTA RICA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 204 COSTA RICAULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 205 COSTA RICA ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 206 COSTA RICA ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 207 COSTA RICA ULTRASOUND IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 208 COSTA RICA RADIOFREQUENCY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 209 COSTA RICA LOW-LEVEL LASER THERAPY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 210 COSTA RICA MINIMALLY INVASIVE IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 211 COSTA RICA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 212 COSTA RICA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 213 COSTA RICA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 214 COSTA RICA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (USD MILLION)
TABLE 215 COSTA RICA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 216 COSTA RICA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 ASP
TABLE 217 COSTA RICA KYBELLA/BELKYRA IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 218 COSTA RICA PHOSPHATIDYLCHOLINE IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 219 COSTA RICA FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 220 COSTA RICA FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 221 COSTA RICA FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP
TABLE 222 COSTA RICA FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 223 COSTA RICA FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 224 COSTA RICA FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP
TABLE 225 COSTA RICA FAT REDUCTION MARKET, BY GENDER, 2019-2033 (USD MILLION)
TABLE 226 COSTA RICA FAT REDUCTION MARKET, BY AGE GROUP, 2019-2033 (USD MILLION)
TABLE 227 COSTA RICA FAT REDUCTION MARKET, BY END USER, 2019-2033 (USD MILLION)
TABLE 228 COSTA RICA HOSPITALS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 229 COSTA RICA HOSPITALS IN FAT REDUCTION MARKET, BY CATEGORY, 2019-2033 (USD MILLION)
TABLE 230 COSTA RICA FAT REDUCTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2033 (USD MILLION)
TABLE 231 DOMINICAN REPUBLIC FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 232 DOMINICAN REPUBLIC SURGICAL FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 233 DOMINICAN REPUBLIC LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 234 DOMINICAN REPUBLIC LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 235 DOMINICAN REPUBLIC LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 236 DOMINICAN REPUBLIC LIPOSUCTION IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 237 DOMINICAN REPUBLIC FACIAL FAT-DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 238 DOMINICAN REPUBLIC SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 239 DOMINICAN REPUBLIC SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 240 DOMINICAN REPUBLIC SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 241 DOMINICAN REPUBLIC CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (USD MILLION)
TABLE 242 DOMINICAN REPUBLIC CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 243 DOMINICAN REPUBLIC CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 ASP
TABLE 244 DOMINICAN REPUBLIC PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 245 DOMINICAN REPUBLIC PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 246 DOMINICAN REPUBLIC PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 247 DOMINICAN REPUBLIC NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 248 DOMINICAN REPUBLIC NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 249 DOMINICAN REPUBLIC NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 250 DOMINICAN REPUBLIC CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 251 DOMINICAN REPUBLIC CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 252 DOMINICAN REPUBLIC CRYOLYPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 253 DOMINICAN REPUBLIC CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 254 DOMINICAN REPUBLICULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 255 DOMINICAN REPUBLIC ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 256 DOMINICAN REPUBLIC ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 257 DOMINICAN REPUBLIC ULTRASOUND IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 258 DOMINICAN REPUBLIC RADIOFREQUENCY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 259 DOMINICAN REPUBLIC LOW-LEVEL LASER THERAPY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 260 DOMINICAN REPUBLIC MINIMALLY INVASIVE IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 261 DOMINICAN REPUBLIC INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 262 DOMINICAN REPUBLIC INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 263 DOMINICAN REPUBLIC INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 264 DOMINICAN REPUBLIC DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (USD MILLION)
TABLE 265 DOMINICAN REPUBLIC DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 266 DOMINICAN REPUBLIC DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 ASP
TABLE 267 DOMINICAN REPUBLIC KYBELLA/BELKYRA IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 268 DOMINICAN REPUBLIC PHOSPHATIDYLCHOLINE IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 269 DOMINICAN REPUBLIC FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 270 DOMINICAN REPUBLIC FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 271 DOMINICAN REPUBLIC FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP
TABLE 272 DOMINICAN REPUBLIC FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 273 DOMINICAN REPUBLIC FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 274 DOMINICAN REPUBLIC FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP
TABLE 275 DOMINICAN REPUBLIC FAT REDUCTION MARKET, BY GENDER, 2019-2033 (USD MILLION)
TABLE 276 DOMINICAN REPUBLIC FAT REDUCTION MARKET, BY AGE GROUP, 2019-2033 (USD MILLION)
TABLE 277 DOMINICAN REPUBLIC FAT REDUCTION MARKET, BY END USER, 2019-2033 (USD MILLION)
TABLE 278 DOMINICAN REPUBLIC HOSPITALS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 279 DOMINICAN REPUBLIC HOSPITALS IN FAT REDUCTION MARKET, BY CATEGORY, 2019-2033 (USD MILLION)
TABLE 280 DOMINICAN REPUBLIC FAT REDUCTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2033 (USD MILLION)
TABLE 281 PANAMA FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 282 PANAMA SURGICAL FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 283 PANAMA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 284 PANAMA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 285 PANAMA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 286 PANAMA LIPOSUCTION IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 287 PANAMA FACIAL FAT-DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 288 PANAMA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 289 PANAMA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 290 PANAMA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 291 PANAMA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (USD MILLION)
TABLE 292 PANAMA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 293 PANAMA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 ASP
TABLE 294 PANAMA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 295 PANAMA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 296 PANAMA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 297 PANAMA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 298 PANAMA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 299 PANAMA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 300 PANAMA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 301 PANAMA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 302 PANAMA CRYOLYPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 303 PANAMA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 304 PANAMAULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 305 PANAMA ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 306 PANAMA ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 307 PANAMA ULTRASOUND IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 308 PANAMA RADIOFREQUENCY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 309 PANAMA LOW-LEVEL LASER THERAPY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 310 PANAMA MINIMALLY INVASIVE IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 311 PANAMA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 312 PANAMA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 313 PANAMA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 314 PANAMA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (USD MILLION)
TABLE 315 PANAMA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 316 PANAMA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 ASP
TABLE 317 PANAMA KYBELLA/BELKYRA IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 318 PANAMA PHOSPHATIDYLCHOLINE IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 319 PANAMA FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 320 PANAMA FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 321 PANAMA FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP
TABLE 322 PANAMA FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 323 PANAMA FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 324 PANAMA FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP
TABLE 325 PANAMA FAT REDUCTION MARKET, BY GENDER, 2019-2033 (USD MILLION)
TABLE 326 PANAMA FAT REDUCTION MARKET, BY AGE GROUP, 2019-2033 (USD MILLION)
TABLE 327 PANAMA FAT REDUCTION MARKET, BY END USER, 2019-2033 (USD MILLION)
TABLE 328 PANAMA HOSPITALS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 329 PANAMA HOSPITALS IN FAT REDUCTION MARKET, BY CATEGORY, 2019-2033 (USD MILLION)
TABLE 330 PANAMA FAT REDUCTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2033 (USD MILLION)
TABLE 331 EL SALVADOR FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 332 EL SALVADOR SURGICAL FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 333 EL SALVADOR LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 334 EL SALVADOR LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 335 EL SALVADOR LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 336 EL SALVADOR LIPOSUCTION IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 337 EL SALVADOR FACIAL FAT-DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 338 EL SALVADOR SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 339 EL SALVADOR SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 340 EL SALVADOR SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 341 EL SALVADOR CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (USD MILLION)
TABLE 342 EL SALVADOR CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 343 EL SALVADOR CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 ASP
TABLE 344 EL SALVADOR PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 345 EL SALVADOR PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 346 EL SALVADOR PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 347 EL SALVADOR NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 348 EL SALVADOR NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 349 EL SALVADOR NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 350 EL SALVADOR CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 351 EL SALVADOR CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 352 EL SALVADOR CRYOLYPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 353 EL SALVADOR CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 354 EL SALVADORULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 355 EL SALVADOR ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 356 EL SALVADOR ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 357 EL SALVADOR ULTRASOUND IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 358 EL SALVADOR RADIOFREQUENCY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 359 EL SALVADOR LOW-LEVEL LASER THERAPY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 360 EL SALVADOR MINIMALLY INVASIVE IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 361 EL SALVADOR INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 362 EL SALVADOR INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 363 EL SALVADOR INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 364 EL SALVADOR DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (USD MILLION)
TABLE 365 EL SALVADOR DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 366 EL SALVADOR DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 ASP
TABLE 367 EL SALVADOR KYBELLA/BELKYRA IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 368 EL SALVADOR PHOSPHATIDYLCHOLINE IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 369 EL SALVADOR FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 370 EL SALVADOR FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 371 EL SALVADOR FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP
TABLE 372 EL SALVADOR FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 373 EL SALVADOR FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 374 EL SALVADOR FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP
TABLE 375 EL SALVADOR FAT REDUCTION MARKET, BY GENDER, 2019-2033 (USD MILLION)
TABLE 376 EL SALVADOR FAT REDUCTION MARKET, BY AGE GROUP, 2019-2033 (USD MILLION)
TABLE 377 EL SALVADOR FAT REDUCTION MARKET, BY END USER, 2019-2033 (USD MILLION)
TABLE 378 EL SALVADOR HOSPITALS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 379 EL SALVADOR HOSPITALS IN FAT REDUCTION MARKET, BY CATEGORY, 2019-2033 (USD MILLION)
TABLE 380 EL SALVADOR FAT REDUCTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2033 (USD MILLION)
TABLE 381 GUATEMALA FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 382 GUATEMALA SURGICAL FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 383 GUATEMALA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 384 GUATEMALA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 385 GUATEMALA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 386 GUATEMALA LIPOSUCTION IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 387 GUATEMALA FACIAL FAT-DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 388 GUATEMALA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 389 GUATEMALA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 390 GUATEMALA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 391 GUATEMALA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (USD MILLION)
TABLE 392 GUATEMALA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 393 GUATEMALA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 ASP
TABLE 394 GUATEMALA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 395 GUATEMALA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 396 GUATEMALA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 397 GUATEMALA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 398 GUATEMALA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 399 GUATEMALA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 400 GUATEMALA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 401 GUATEMALA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 402 GUATEMALA CRYOLYPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 403 GUATEMALA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 404 GUATEMALAULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 405 GUATEMALA ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 406 GUATEMALA ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 407 GUATEMALA ULTRASOUND IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 408 GUATEMALA RADIOFREQUENCY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 409 GUATEMALA LOW-LEVEL LASER THERAPY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 410 GUATEMALA MINIMALLY INVASIVE IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 411 GUATEMALA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 412 GUATEMALA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 413 GUATEMALA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 414 GUATEMALA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (USD MILLION)
TABLE 415 GUATEMALA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 416 GUATEMALA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 ASP
TABLE 417 GUATEMALA KYBELLA/BELKYRA IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 418 GUATEMALA PHOSPHATIDYLCHOLINE IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 419 GUATEMALA FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 420 GUATEMALA FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 421 GUATEMALA FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP
TABLE 422 GUATEMALA FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 423 GUATEMALA FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 424 GUATEMALA FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP
TABLE 425 GUATEMALA FAT REDUCTION MARKET, BY GENDER, 2019-2033 (USD MILLION)
TABLE 426 GUATEMALA FAT REDUCTION MARKET, BY AGE GROUP, 2019-2033 (USD MILLION)
TABLE 427 GUATEMALA FAT REDUCTION MARKET, BY END USER, 2019-2033 (USD MILLION)
TABLE 428 GUATEMALA HOSPITALS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 429 GUATEMALA HOSPITALS IN FAT REDUCTION MARKET, BY CATEGORY, 2019-2033 (USD MILLION)
TABLE 430 GUATEMALA FAT REDUCTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2033 (USD MILLION)
TABLE 431 HONDURAS FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 432 HONDURAS SURGICAL FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 433 HONDURAS LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 434 HONDURAS LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 435 HONDURAS LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 436 HONDURAS LIPOSUCTION IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 437 HONDURAS FACIAL FAT-DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 438 HONDURAS SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 439 HONDURAS SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 440 HONDURAS SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 441 HONDURAS CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (USD MILLION)
TABLE 442 HONDURAS CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 443 HONDURAS CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 ASP
TABLE 444 HONDURAS PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 445 HONDURAS PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 446 HONDURAS PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 447 HONDURAS NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 448 HONDURAS NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 449 HONDURAS NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 450 HONDURAS CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 451 HONDURAS CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 452 HONDURAS CRYOLYPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 453 HONDURAS CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 454 HONDURASULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 455 HONDURAS ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 456 HONDURAS ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 457 HONDURAS ULTRASOUND IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 458 HONDURAS RADIOFREQUENCY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 459 HONDURAS LOW-LEVEL LASER THERAPY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 460 HONDURAS MINIMALLY INVASIVE IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 461 HONDURAS INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 462 HONDURAS INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 463 HONDURAS INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 464 HONDURAS DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (USD MILLION)
TABLE 465 HONDURAS DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 466 HONDURAS DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 ASP
TABLE 467 HONDURAS KYBELLA/BELKYRA IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 468 HONDURAS PHOSPHATIDYLCHOLINE IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 469 HONDURAS FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 470 HONDURAS FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 471 HONDURAS FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP
TABLE 472 HONDURAS FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 473 HONDURAS FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 474 HONDURAS FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP
TABLE 475 HONDURAS FAT REDUCTION MARKET, BY GENDER, 2019-2033 (USD MILLION)
TABLE 476 HONDURAS FAT REDUCTION MARKET, BY AGE GROUP, 2019-2033 (USD MILLION)
TABLE 477 HONDURAS FAT REDUCTION MARKET, BY END USER, 2019-2033 (USD MILLION)
TABLE 478 HONDURAS HOSPITALS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 479 HONDURAS HOSPITALS IN FAT REDUCTION MARKET, BY CATEGORY, 2019-2033 (USD MILLION)
TABLE 480 HONDURAS FAT REDUCTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2033 (USD MILLION)
TABLE 481 NICARAGUA FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 482 NICARAGUA SURGICAL FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 483 NICARAGUA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 484 NICARAGUA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 485 NICARAGUA LIPOSUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 486 NICARAGUA LIPOSUCTION IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 487 NICARAGUA FACIAL FAT-DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 488 NICARAGUA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 489 NICARAGUA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 490 NICARAGUA SURGICAL REJUVENATION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 491 NICARAGUA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (USD MILLION)
TABLE 492 NICARAGUA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 493 NICARAGUA CHIN IMPLANT IN FAT REDUCTION MARKET, BY SMOOTH IMPLANTS, 2019-2033 ASP
TABLE 494 NICARAGUA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 495 NICARAGUA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 496 NICARAGUA PORUS IMPLANTS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 497 NICARAGUA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 498 NICARAGUA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 499 NICARAGUA NON-INVASIVE FAT REDUCTION IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 500 NICARAGUA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 501 NICARAGUA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 502 NICARAGUA CRYOLYPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 503 NICARAGUA CRYOLIPOLYSIS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 504 NICARAGUAULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 505 NICARAGUA ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 506 NICARAGUA ULTRASOUND IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 507 NICARAGUA ULTRASOUND IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 508 NICARAGUA RADIOFREQUENCY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 509 NICARAGUA LOW-LEVEL LASER THERAPY IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 510 NICARAGUA MINIMALLY INVASIVE IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 511 NICARAGUA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 512 NICARAGUA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 513 NICARAGUA INJECTION LIPOLYSIS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 ASP
TABLE 514 NICARAGUA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (USD MILLION)
TABLE 515 NICARAGUA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 516 NICARAGUA DEOXYCHOLIC ACID INJECTIONS IN FAT REDUCTION MARKET, BY BRAND, 2019-2033 ASP
TABLE 517 NICARAGUA KYBELLA/BELKYRA IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 518 NICARAGUA PHOSPHATIDYLCHOLINE IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 519 NICARAGUA FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 520 NICARAGUA FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 521 NICARAGUA FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP
TABLE 522 NICARAGUA FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (USD MILLION)
TABLE 523 NICARAGUA FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 (NUMBER OF PROCEDURES)
TABLE 524 NICARAGUA FACIAL FAT DEPOSITS IN FAT REDUCTION MARKET, BY APPLICATION, 2019-2033 ASP
TABLE 525 NICARAGUA FAT REDUCTION MARKET, BY GENDER, 2019-2033 (USD MILLION)
TABLE 526 NICARAGUA FAT REDUCTION MARKET, BY AGE GROUP, 2019-2033 (USD MILLION)
TABLE 527 NICARAGUA FAT REDUCTION MARKET, BY END USER, 2019-2033 (USD MILLION)
TABLE 528 NICARAGUA HOSPITALS IN FAT REDUCTION MARKET, BY TYPE, 2019-2033 (USD MILLION)
TABLE 529 NICARAGUA HOSPITALS IN FAT REDUCTION MARKET, BY CATEGORY, 2019-2033 (USD MILLION)
TABLE 530 NICARAGUA FAT REDUCTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2033 (USD MILLION)
그림 목록
FIGURE 1 NORTH AMERICA FAT REDUCTION MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA FAT REDUCTION MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA FAT REDUCTION MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA FAT REDUCTION MARKET: COUNTRY VS. REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA FAT REDUCTION MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA FAT REDUCTION MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 NORTH AMERICA FAT REDUCTION MARKET: MULTIVARIATE MODELLING
FIGURE 8 NORTH AMERICA FAT REDUCTION MARKET: DBMR MARKET POSITION GRID
FIGURE 9 NORTH AMERICA FAT REDUCTION MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 NORTH AMERICA FAT REDUCTION MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 11 NORTH AMERICA FAT REDUCTION MARKET: SEGMENTATION
FIGURE 12 INCREASING DEMAND FOR NON-INVASIVE AND MINIMALLY INVASIVE AESTHETIC PROCEDURES IS EXPECTED TO DRIVE THE NORTH AMERICA FAT REDUCTION MARKET GROWTH IN THE FORECAST PERIOD FROM 2023 TO 2033
FIGURE 13 THE SURGICAL FAT REDUCTION SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA FAT REDUCTION MARKET IN 2023 & 2033
FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE NORTH AMERICA FAT REDUCTION MARKET
FIGURE 15 NORTH AMERICA FAT REDUCTION MARKET: BY TYPE, 2022
FIGURE 16 NORTH AMERICA FAT REDUCTION MARKET: BY TYPE, 2023-2033 (USD MILLION)
FIGURE 17 NORTH AMERICA FAT REDUCTION MARKET: BY TYPE, CAGR (2023-2033)
FIGURE 18 NORTH AMERICA FAT REDUCTION MARKET: BY TYPE, LIFELINE CURVE
FIGURE 19 NORTH AMERICA FAT REDUCTION MARKET: BY APPLICATION, 2022
FIGURE 20 NORTH AMERICA FAT REDUCTION MARKET: BY APPLICATION, 2023-2033 (USD MILLION)
FIGURE 21 NORTH AMERICA FAT REDUCTION MARKET: BY APPLICATION, CAGR (2023-2033)
FIGURE 22 NORTH AMERICA FAT REDUCTION MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 23 NORTH AMERICA FAT REDUCTION MARKET: BY GENDER, 2022
FIGURE 24 NORTH AMERICA FAT REDUCTION MARKET: BY GENDER, 2023-2033 (USD MILLION)
FIGURE 25 NORTH AMERICA FAT REDUCTION MARKET: BY GENDER, CAGR (2023-2033)
FIGURE 26 NORTH AMERICA FAT REDUCTION MARKET: BY GENDER, LIFELINE CURVE
FIGURE 27 NORTH AMERICA FAT REDUCTION MARKET: BY AGE GROUP, 2022
FIGURE 28 NORTH AMERICA FAT REDUCTION MARKET: BY AGE GROUP, 2023-2033 (USD MILLION)
FIGURE 29 NORTH AMERICA FAT REDUCTION MARKET: BY AGE GROUP, CAGR (2023-2033)
FIGURE 30 NORTH AMERICA FAT REDUCTION MARKET: BY AGE GROUP, LIFELINE CURVE
FIGURE 31 NORTH AMERICA FAT REDUCTION MARKET: BY END USER, 2022
FIGURE 32 NORTH AMERICA FAT REDUCTION MARKET: BY END USER, 2023-2033 (USD MILLION)
FIGURE 33 NORTH AMERICA FAT REDUCTION MARKET: BY END USER, CAGR (2023-2033)
FIGURE 34 NORTH AMERICA FAT REDUCTION MARKET: BY END USER, LIFELINE CURVE
FIGURE 35 NORTH AMERICA FAT REDUCTION MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 36 NORTH AMERICA FAT REDUCTION MARKET: BY DISTRIBUTION CHANNEL, 2023-2033 (USD MILLION)
FIGURE 37 NORTH AMERICA FAT REDUCTION MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2033)
FIGURE 38 NORTH AMERICA FAT REDUCTION MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 39 NORTH AMERICA FAT REDUCTION MARKET: SNAPSHOT (2022)
FIGURE 40 NORTH AMERICA FAT REDUCTION MARKET: BY COUNTRY (2022)
FIGURE 41 NORTH AMERICA FAT REDUCTION MARKET: BY COUNTRY (2023 & 2033)
FIGURE 42 NORTH AMERICA FAT REDUCTION MARKET: BY COUNTRY (2022 & 2033)
FIGURE 43 NORTH AMERICA FAT REDUCTION MARKET: BY TYPE (2023-2033)
FIGURE 44 NORTH AMERICA FAT REDUCTION MARKET: COMPANY SHARE 2022 (%)
연구 방법론
데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.
DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.
사용자 정의 가능
Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.
